Clinical Trials List
Protocol NumberSCAS001
2025-05-01 - 2027-12-31
Phase II
Recruiting1
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李薰華 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
0-39(競爭型收案) participants
-
Global
39 participants
